Long term effects of ketogenic diet in obese subjects with high cholesterol level
- PMID: 16652223
- DOI: 10.1007/s11010-005-9001-x
Long term effects of ketogenic diet in obese subjects with high cholesterol level
Abstract
Objective: Various studies have convincingly shown the beneficial effect of ketogenic diet (in which the daily consumption of carbohydrate is less than 20 grams, regardless of fat, protein and caloric intake) in reducing weight in obese subjects. However, its long term effect on obese subjects with high total cholesterol (as compared to obese subjects with normal cholesterol level is lacking. It is believed that ketogenic diet may have adverse effect on the lipid profile. Therefore, in this study the effect of ketogenic diet in obese subjects with high cholesterol level above 6 mmol/L is compared to those with normocholesterolemia for a period of 56 weeks.
Materials and methods: In this study, 66 healthy obese subjects with body mass index (BMI) greater than 30, having high cholesterol level (Group I; n = 35) and those subjects with normal cholesterol level (Group II; n = 31) were selected. The body weight, body mass index, total cholesterol, LDL-cholesterol, HDL-cholesterol, urea, creatinine, glucose and triglycerides were determined before and after the administration of the ketogenic diet. Changes in these parameters were monitored at 8, 16, 24, 32, 40, 48 and 56 weeks of the treatment.
Results: The body weight and body mass index of both groups decreased significantly (P < 0.0001). The level of total cholesterol, LDL cholesterol, triglycerides and blood glucose level decreased significantly (P < 0.0001), whereas HDL cholesterol increased significantly (P < 0.0001) after the treatment in both groups.
Conclusion: This study shows the beneficial effects of ketogenic diet following its long term administration in obese subjects with a high level of total cholesterol. Moreover, this study demonstrates that low carbohydrate diet is safe to use for a longer period of time in obese subjects with a high total cholesterol level and those with normocholesterolemia.
Similar articles
-
Beneficial effects of ketogenic diet in obese diabetic subjects.Mol Cell Biochem. 2007 Aug;302(1-2):249-56. doi: 10.1007/s11010-007-9448-z. Epub 2007 Apr 20. Mol Cell Biochem. 2007. PMID: 17447017 Clinical Trial.
-
Long-term effects of a ketogenic diet in obese patients.Exp Clin Cardiol. 2004 Fall;9(3):200-5. Exp Clin Cardiol. 2004. PMID: 19641727 Free PMC article.
-
Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes.Nutrition. 2012 Oct;28(10):1016-21. doi: 10.1016/j.nut.2012.01.016. Epub 2012 Jun 5. Nutrition. 2012. PMID: 22673594 Clinical Trial.
-
Effect of a Ketogenic Diet on the Nutritional Parameters of Obese Patients: A Systematic Review and Meta-Analysis.Nutrients. 2021 Aug 25;13(9):2946. doi: 10.3390/nu13092946. Nutrients. 2021. PMID: 34578824 Free PMC article.
-
The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1-3a CKD patients.Clin Kidney J. 2023 Jul 18;16(12):2309-2313. doi: 10.1093/ckj/sfad176. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38045995 Free PMC article. Review.
Cited by
-
Metformin Prevents Fatty Liver and Improves Balance of White/Brown Adipose in an Obesity Mouse Model by Inducing FGF21.Mediators Inflamm. 2016;2016:5813030. doi: 10.1155/2016/5813030. Epub 2016 Jan 19. Mediators Inflamm. 2016. PMID: 27057099 Free PMC article.
-
Impact of diet restriction in the management of diabetes: evidences from preclinical studies.Naunyn Schmiedebergs Arch Pharmacol. 2018 Mar;391(3):235-245. doi: 10.1007/s00210-017-1453-5. Epub 2017 Dec 16. Naunyn Schmiedebergs Arch Pharmacol. 2018. PMID: 29249036 Review.
-
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE).J Endocrinol Invest. 2019 Nov;42(11):1365-1386. doi: 10.1007/s40618-019-01061-2. Epub 2019 May 20. J Endocrinol Invest. 2019. PMID: 31111407
-
Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD-a randomized controlled trial.Cell Rep Med. 2023 Nov 21;4(11):101283. doi: 10.1016/j.xcrm.2023.101283. Epub 2023 Nov 7. Cell Rep Med. 2023. PMID: 37935200 Free PMC article. Clinical Trial.
-
Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague-Dawley rats.Nutr Metab (Lond). 2016 Feb 4;13:9. doi: 10.1186/s12986-016-0069-y. eCollection 2016. Nutr Metab (Lond). 2016. PMID: 26855664 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical